Atlas Trials

Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT03660683 · TERMINATED

Trial details

NCT number
NCT03660683
Sponsor
Sabyasachi Sen
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Cardiovascular Diseases
Start date
2018-10-22
Primary completion
2021-03-11
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.